Moreover, both serum NfL and serum GFAP levels are associated with cognitive functioning in RVCL-S, showing the potential of these neuronal injury and astrogliosis biomarkers for monitoring disease progression and cognitive decline for SVD. The gene discussed is GFAP; the disease is snowflake vitreoretinal degeneration.